Cargando…
The Association Between COVID-19 Mortality and ICU Admission Rates and Prior History of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use Among Hospitalized COVID-19 Patients With Hypertension in Michigan
Importance There are conflicting data regarding the safety of the use of angiotensin-converting enzyme inhibitor or angiotensin receptor blocker (ACEI/ARB) medications in hypertensive patients who are susceptible to COVID-19. Objective Our study assesses the association between COVID-19 severity and...
Autores principales: | Elhouderi, Eiman, Elsawalhy, Eman, Al-Sudani, Najlaa, Mahmood, Irum, Sengstock, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10516143/ https://www.ncbi.nlm.nih.gov/pubmed/37746496 http://dx.doi.org/10.7759/cureus.43980 |
Ejemplares similares
-
Myopericarditis After mRNA COVID-19 Vaccine in a Patient With Recent History of COVID-19
por: Elhouderi, Eiman, et al.
Publicado: (2022) -
Renin-Angiotensin-Aldosterone System Blockers Prior to Hospitalization and Their Association With Clinical Outcomes in Coronavirus Disease 2019 (COVID-19)
por: Banwait, Ranjit, et al.
Publicado: (2021) -
Comparison Between Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers for Incidence of Lung Cancer: A Retrospective Study
por: Kumar, Pardeep, et al.
Publicado: (2021) -
Impact of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers on Renal Function in Chronic Kidney Disease Patients Undergoing Coronary Angiography
por: Motes, Arunee T, et al.
Publicado: (2021) -
Effects of angiotensin receptor blockers and angiotensin-converting enzyme inhibitors on COVID-19
por: Li, Xiao-Long, et al.
Publicado: (2021)